Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
Vale SA
VALE
KB Home
KBH
Apple
AAPL
US Stock MarketDetailed Quotes
SLN Silence Therapeutics
- 4.840
- +0.340+7.56%
Close Feb 14 16:00 ET
228.52MMarket Cap-2.85P/E (TTM)
5.121High4.460Low550.05KVolume4.550Open4.500Pre Close2.66MTurnover2.23%Turnover RatioLossP/E (Static)47.21MShares27.72052wk High1.92P/B119.38MFloat Cap4.06052wk Low--Dividend TTM24.66MShs Float35.000Historical High--Div YieldTTM14.68%Amplitude4.060Historical Low4.835Avg Price1Lot Size
About Silence Therapeutics Company
Silence Therapeutics Plc engages in the discovery, delivery, and development of ribonucleic acid (RNA) therapeutics. It also develops medicines by harnessing the body's natural mechanism of RNA interference within its cells. The company was founded on November 18, 1994 and is headquartered in London, the United Kingdom.
Company Profile
SymbolSLN
Company NameSilence Therapeutics
Founded1994
CEOMr. Craig A. Tooman
MarketNASDAQ
Employees109
Securities TypeDR
ADS Ratio1.0 : 3.0
Fiscal Year Ends12-31
Address72 Hammersmith Road
CityLondon
ProvinceGreater London
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeW14 8TH
Phone44-20-3457-6900
Company Executives
- Name
- Position
- Salary
- Craig A. Tooman
- President, Chief Executive Officer and Director
- 7.30M
- Rhonda L. Hellums
- Chief Financial Officer
- 2.50M
- Iain Gladstone Ross
- Non-Executive Chairman of the Board
- 402.00K
- David Jakob Lemus
- Independent Director
- 184.00K
- Alistair William Gray
- Senior Independent Director
- 193.00K
- Dr. Michael Harvey Davidson, M.D.
- Independent Director
- 178.00K
- James Lawrence Ede-Golightly
- Independent Director
- 182.00K
- Dr. Steven Joseph Romano, M.D.
- Head of Research and Development
- 1.73M
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.